By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

G1 Therapeutics 



Chapel Hill  North Carolina    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
University of North Carolina Spinout G1 Therapeutics Locks in $47 Million Series C Financing 5/12/2016 6:37:54 AM
G1 Therapeutics To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 11:21:38 AM
G1 Therapeutics To Present At The Stifel 2015 Healthcare Conference 11/10/2015 8:36:04 AM
Glenn P. Muir Appointed To G1 Therapeutics Board Of Directors 10/21/2015 7:40:29 AM
G1 Therapeutics To Present At September Biotech Conferences 9/3/2015 7:29:31 AM
G1 Therapeutics Announces Initiation Of Two Phase Ib/IIa Trials Of CDK4/6 Inhibitor G1T28 In Small-Cell Lung Cancer 8/11/2015 7:45:09 AM
G1 Therapeutics To Present At August Investor Conferences 8/5/2015 11:06:58 AM
G1 Therapeutics To Present At The BIO International Convention 6/10/2015 8:01:48 AM
G1 Therapeutics Announces Positive Phase Ia Data For CDK4/6 Inhibitor G1T28 5/27/2015 7:18:01 AM
G1 Therapeutics To Present New Data On CDK4/6 Inhibitor G1T28 At The 2015 ASCO Annual Meeting 5/14/2015 10:33:26 AM
123
//-->